Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy

Peptides

Volumn 42, Issue , 2013, Pages 125-130

  Banki, E ^a   Degrell, P ^b   Kiss, P ^a   Kovacs, K ^b   Kemeny, A ^a   Csanaky, K ^a   Duh, A ^a   Nagy, D ^a   Toth, G ^c   Tamas, A ^a   Reglodi, D ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DOSE RESPONSE; DOWN REGULATION; GLOMERULUS; GLUCOSE BLOOD LEVEL; HISTOLOGY; HYALINE DEGENERATION; KIDNEY MASS; MALE; MORPHOLOGY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; SURVIVAL; TREATMENT DURATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHEMOKINE CXCL1; CHEMOKINE CXCL9; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; KIDNEY; MALE; ORGAN SIZE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS, WISTAR; STREPTOZOCIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84874550358     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.02.002     Document Type: Article

References (48)

1. M. Abbate, C. Zoja, and G. Remuzzi How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17 2006 2974 2984
2. A. Arimura, M. Li, and V. Batuman Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury Blood 107 2006 661 668
3. D.E. Brenneman, J.M. Hauser, C. Spong, and T.M. Phillips Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity Neuropeptides 36 2002 271 280
4. C.M. Bruno, M. Valenti, G. Bertino, A. Ardiri, F. Bruno, and M. Cunsolo Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria Minerva Med 99 2008 1 5
5. J.M. Catania, G. Chen, and A.R. Parrish Role of metalloproteinases in renal pathophysiologies Am J Physiol Renal Physiol 292 2007 F905 F911
6. S. Chen, S.W. Hong, M.C. Iglesias-de la Cruz, M. Isono, A. Casaretto, and F.N. Ziyadeh The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy Ren Fail 23 2001 471 481
7. D. Cugini, N. Azzollini, E. Gagliardini, P. Cassis, R. Bertini, and F. Colotta Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion Kidney Int 67 2005 1753 1761
8. Darsalia V, Ortsater H, Olverling A, Darlof E, Wolbert P, Nystrom T, et al. The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain. Diabetes, PMID 23209191, in press.
9. M. Delgado, G.M. Jonakait, and D. Ganea Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia Glia 39 2002 148 161
10. D. Dragun, U. Hoff, J.K. Park, Y. Qun, W. Schneider, and F.C. Luft Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background Kidney Int 58 2000 2166 2177
11. K. Elekes, K. Sandor, A. Moricz, L. Kereskai, A. Kemeny, and E. Szoke Pituitary adenylate cyclase activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: in vivo study with gene-deleted mice Peptides 32 2011 1439 1446
12. R.J. Falk, J.I. Scheinman, S.M. Mauer, and A.F. Michael Polyantigenic expansion of basement membrane constituents in diabetic nephropathy Diabetes 32 SUPPL. 2 1983 34 39
13. B.M. Girard, S.E. Malley, K.M. Braas, V. May, and M.A. Vizzard PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium J Mol Neurosci 42 2010 378 389
14. M. Higurashi, Y. Ohya, K. Joh, M. Muraguchi, M. Nishimura, and H. Terawaki Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy J Diabetes Complications 23 2009 178 184
15. G. Horvath, R. Brubel, K. Kovacs, D. Reglodi, B. Opper, and A. Ferencz Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells J Mol Neurosci 43 2011 67 75
16. M. Kanauchi, H. Nishioka, Y. Nakashima, T. Hashimoto, and K. Dohi Role of tissue inhibitors of metalloproteinase in diabetic nephropathy Nippon Jinzo Gakkai Shi 38 1996 124 128
17. A.M. Khan, M. Li, S. Abdulnour-Nakhoul, J.L. Maderdrut, E.E. Simon, and V. Batuman Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptors Peptides 38 2012 395 403
18. A.M. Khan, M. Li, E. Brant, J.L. Maderdrut, D.S. Majid, and E.E. Simon Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity J Investig Med 59 2011 793 802
19. K.F. Kock, and V. Vestergaard Armanni-Ebstein lesions of the kidney: diagnostic of death in diabetic coma Forensic Sci Int 67 1994 169 174
20. M. Li, J.L. Maderdrut, J.J. Lertora, A. Arimura, and V. Batuman Renoprotection by pituitary adenylate cyclase activating polypeptide in multiple myeloma and other kidney diseases Regul Pept 145 2008 24 32
21. W.J. Liu, S.H. Xie, Y.N. Liu, W. Kim, H.Y. Jin, and S.K. Park Dipeptidyl peptidase IV inhibitor attenuates kidney in streptozotocin-induced diabetic rats J Pharmacol Exp Ther 340 2012 248 255
22. L.C. Matavelli, and H.M. Siragy Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats J Cardiovasc Pharmacol 61 2013 17 22
23. A. Mizutani, K. Okajima, M. Uchiba, and T. Noguchi Activated protein C reduces ischaemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation Blood 95 2000 3781 3787
24. J.F. Navarro-González, C. Mora-Fernández, M. Muros de Fuentes, and J. García-Pérez Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy Nat Rev Nephrol 7 2011 327 340
25. K. Nedvig, J. Weber Gy Nemeth, K. Kovacs, D. Reglodi, and A. Kemeny Intestinal autotransplantation using PACAP-38-containing preservation solution J Mol Neurosci 48 2012 788 794
26. W. Qi, X. Chen, Y. Zhang, J. Holian, E. Mreich, and R.E. Gilbert High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism Nephrol Dial Transplant 22 2007 3147 3153
27. D. Reglodi, P. Kiss, G. Horvath, A. Lubics, E. Laszlo, and A. Tamas Effects of pituitary adenylate cyclase activating polypeptide in the urinary system, with special emphasis on its protective effects in the kidney Neuropeptides 46 2012 61 70
28. D. Reglodi, P. Kiss, K. Szabadfi, T. Atlasz, R. Gabriel, and G. Horvath PACAP is an endogenous protective factor-insights from PACAP deficient mice J Mol Neurosci 48 2012 482 492
29. L.F. Rezende, G.J. Santos, E.M. Carneiro, and A.C. Bodschero Ciliary neurotrophic factor protects mice against streptozotocin-induced type I diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death J Biol Chem 287 2012 41628 41639
30. Y. Sakuma, C. Ricordi, A. Miki, T. Yamamoto, A. Mita, and S. Barker Effect of pituitary adenylate cyclase-activating polypeptide in islet transplantation Transplant Proc 41 2009 343 345
31. A. Sanchez, D. Tripathy, and P. Grammas RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons Neuropeptides 43 2009 315 320
32. K. Shikata, Y. Suzuki, J. Wada, K. Hirata, M. Matsuda, and H. Kawashima L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction J Pathol 188 1999 93 99
33. N. Shintani, S. Tomimoto, H. Hashimoto, C. Kawaguchi, and A. Baba Functional roles of the neuropeptide PACAP in brain and pancreas Life Sci 74 2003 337 343
34. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 1994 301 314
35. L.C. Stout, S. Kumar, and E.B. Whorton Insudative lesions-their pathogenesis and association with glomerular obsolescence in diabetes: a dynamic hypohesis based on single views of advancing human diabetic nephropathy Hum Pathol 25 1994 1213 1227
36. K. Szabadfi, T. Atlasz, P. Kiss, D. Reglodi, A. Szabo, and K. Kovacs Protective effects of the neuropeptide PACAP in diabetic retinopathy Cell Tissue Res 348 2012 37 46
37. A. Szabo, B. Danyadi, E. Bognar, K. Szabadfi, E. Fabian, and P. Kiss Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion Neurosci Lett 523 2012 93 98
38. P. Szakaly, P. Kiss, A. Lubics, T. Magyarlaki, A. Tamas, and B. Racz Effects of PACAP on survival and renal morphology in rats subjected to renal ischemia/reperfusion J Mol Neurosci 36 2008 89 96
39. J.L. Taft, C.J. Nolan, S.P. Yeung, T.D. Hewitson, and F.I. Martin Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria Diabetes 43 1994 1046 1051
40. T.W. Tervaert, A.L. Mooyaart, K. Amann, A.H. Cohen, H.T. Cook, and C.B. Drachenberg Pathologic classification of diabetic nephropathy J Am Soc Nephrol 21 2010 556 563
41. G.H. Tesch, and T.J. Allen Rodent models of streptozotocin-induced diabetic nephropathy Nephrology (Carlton) 12 2007 261 266
42. D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, and O. Wurtz Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 2009 283 357
43. A.M. Woltman, J.W. de Fijter, S.W. van der Kooij, K.E. Jie, C. Massacrier, and C. Caux MIP-3alpha/CCL20 in renal transplantation and its possible involvement as dendritic cell chemoattractant in allograft rejection Am J Transplant 5 2005 2114 2125
44. K. Yamamoto, H. Hashimoto, S. Tomimoto, N. Shintani, J. Miyazaki, and F. Tashiro Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes Diabetes 52 2003 1155 1162
45. R. Yu, X. Guo, L. Huang, Z. Zeng, and H. Zhang The novel peptide PACAP-TAT with enhanced traversing ability attenuates the severe lung injury induced by repeated smoke inhalation Peptides 38 2012 142 149
46. K. Zandi-Nejad, A.A. Eddy, R.J. Glassock, and B.M. Brenner Why is proteinuria an ominous biomarker of progressive kidney disease Kidney Int SUPPL. 92 2004 S76 S89
47. H. Zhang, R. Yu, X. Liu, X. Guo, and Z. Zeng The expression of PAC1 increases in the degenerative thymus and low dose PACAP protects female mice from cyclophosphamide induced thymus atrophy Peptides 38 2012 337 343
48. C. Zhou, A.J. Yool, J. Nolan, and R.W. Byard Armanni-Ebstein lesions: a need for clarification J Forensic Sci 58 SUPPL. 1 2013 S94 S98